Combined treatment improves bloatingBeta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome.
Inositol's effect is unclear.
We set out to evaluate how a mixture of beta-glucan, inositol, and digestive enzymes could help ease gastrointestinal discomfort, particularly bloating, in patients suffering from both inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS). Our study involved 43 patients who were already receiving their standard medication. They were divided into two groups: one continued with their regular treatment, while the other received additional support from our special mixture for four weeks.
After this treatment period, we observed notable improvements in the group that received the beta-glucan, inositol, and digestive enzymes. Many patients reported reduced bloating, flatulence, and abdominal pain. Overall, their clinical condition showed significant enhancement, suggesting that these combined ingredients can positively impact the quality of life for individuals battling these challenging gastrointestinal issues.
Read More
Our study aimed to evaluate how effective a combination treatment of beta-glucan, inositol, and digestive enzymes, known as Biointo, is for addressing bloating in patients with irritable bowel syndrome (IBS).
We observed that patients who took Biointo reported improvements in bloating, flatulence, and abdominal pain. Specifically, there was a notable decrease in bloating associated with gas in the intestinal tract. However, we also found that Biointo did not significantly affect other IBS symptoms.
It's important to mention that the overall effectiveness of inositol alone on bloating remains less certain, given it was part of a mixture and tested alongside other ingredients. Therefore, while the treatment shows promise in alleviating specific symptoms, we may need further research to fully understand inositol's distinct impact on bloating.
Read More